MINNEAPOLIS, MN — January 10, 2025 (PR Newswire) Saluda Medical, Inc., a commercial-stage medical device company focused on development treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. FLG Managing Partner Laureen DeBuono assisted as Board of Directors…Read More
“I had great experiences with FLG Partners on multiple occasions. I used to work with FLG Partner, Jonathan Wolter, at PARC, and through his advice I engaged FLG’s Doug Lehrmann when I left PARC to start CyDesign Labs. In fact, I had the pleasure of working with Doug twice at CyDesign. Initially, he joined me on the founding team as Interim CFO. He rejoined a couple of years later to prepare the company for a successful acquisition. Doug kept his calm during these challenging times and provided the company with sound and clear guidance. Through his 30+ years of experience as a CFO, no business circumstance is unfamiliar to him – he has seen it all! Doug has a keen sense of ethics and he ensures that the company records are kept in immaculate order at all times. Both Jon and Doug are truly delightful people to work with!”
Serdar Uckun, Founder & CEO, CyDesign Labs Read More